Simplifying HCV Treatment in Rwanda for Elsewhere in the Developing World: Pangenotypic and Retreatment Study (SHARED3)
NCT03888729
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C, Chronic
Interventions
DRUG:
sofosbubir/velpatasvir
DRUG:
sofosbubir/velpatasvir/voxilaprevir
Sponsor
Partners in Health